Temporomandibular joint arthrography: comparison of morbidity with ionic and low osmolality contrast media.
We compared patient morbidity associated with temporomandibular joint (TMJ) arthrography using both meglumine/sodium diatrizoate (60%) and the new monoacidic dimer, Hexabrix, in a double-blind randomized clinical trial in 31 patients. Patients experienced maximal discomfort from TMJ arthrography with the initial joint filling and joint distension; this rapidly resolved over 10 minutes. Delayed exacerbation of pain is less than described for shoulder arthrography. The newer contrast media promise to decrease patient morbidity with arthrography.
D000328:Adult; D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000633:toxicity*; D003973:Diatrizoate / Q000031:analogs & derivatives*; D003974:Diatrizoate Meglumine / Q000633:toxicity*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007463:Iodobenzoates / Q000633:toxicity*; D007485:Ioxaglic Acid; D008297:Male; D010146:Pain / Q000139:chemically induced; D011859:Radiography; D011897:Random Allocation; D013704:Temporomandibular Joint / Q000000981:diagnostic imaging*; D013997:Time Factors; D014283:Triiodobenzoic Acids / Q000633:toxicity*
D003287:Contrast Media; D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D003973:Diatrizoate; D003974:Diatrizoate Meglumine; D007485:Ioxaglic Acid